Stellar Biotechnologies is a biotechnology company with efforts focused on the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, United States and Asia. KLH is an immune-stimulating protein used for generation of antibody and cell-mediated immune responses against disease indications, such as cancer, immune disorders, Alzheimers, and inflammatory diseases. For more information visit the company website at www.stellarbiotechnologies.com